Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT. Atalar B, et al. Among authors: akyurek s. Radiother Oncol. 2018 Apr;127(1):96-102. doi: 10.1016/j.radonc.2017.12.028. Epub 2018 Jan 17. Radiother Oncol. 2018. PMID: 29373196
Risk factors of radiation pneumonitis in patients with NSCLC treated with concomitant chemoradiotherapy--Are we underestimating diabetes?--Turkish oncology group (TOG)/Lung cancer study group.
Ergen SA, Dincbas FO, Yücel B, Altınok P, Akyurek S, Korkmaz Kıraklı E, Ulger S, Etiz D, Yilmaz U, Kılıc D, Bozcuk H. Ergen SA, et al. Among authors: akyurek s. Clin Respir J. 2020 Sep;14(9):871-879. doi: 10.1111/crj.13220. Epub 2020 Jun 23. Clin Respir J. 2020. PMID: 32470205
Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
Sahin B, Atalar B, Kaytan Saglam E, Akgun Z, Abacioglu U, Arifoglu A, Ozyar E, Yaprak G, Ozseker Isik N, Guney Y, Caglar HB, Karaman S, Igdem S, Selek U, Berber T, Oner Dincbas F, Sengoz M, Yucel S, Demiral AN, Akyurek S. Sahin B, et al. Among authors: akyurek s. Clin Respir J. 2020 Nov;14(11):1050-1059. doi: 10.1111/crj.13240. Epub 2020 Aug 17. Clin Respir J. 2020. PMID: 32749053
Lung Cancer in Turkey.
Cangır AK, Yumuk PF, Sak SD, Akyürek S, Eralp Y, Yılmaz Ü, Selek U, Eroğlu A, Tatlı AM, Dinçbaş FÖ, Kılıçkap S, Şendur MAN, Dilektaşlı AG, Bozcuk HŞ, Özkök S, Öztop İ, Topkan E, Dilege Ş, Kaya A, Demirkazık A; Turk Oncology Group. Cangır AK, et al. Among authors: akyurek s. J Thorac Oncol. 2022 Oct;17(10):1158-1170. doi: 10.1016/j.jtho.2022.06.001. J Thorac Oncol. 2022. PMID: 36192076 Free article. No abstract available.
Reply to "Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas".
Lassen-Ramshad Y, Ozyar E, Alanyali S, Poortmans P, Van Houtte P, Sohawon S, Esassolak M, Krengli M, Villa S, Miller RC, Demiroz C, Akyurek S, Aggerholm-Pedersen N, Thariat J. Lassen-Ramshad Y, et al. Among authors: akyurek s. Head Neck. 2019 Aug;41(8):2837-2838. doi: 10.1002/hed.25800. Epub 2019 May 6. Head Neck. 2019. PMID: 31058391 No abstract available.
58 results